baber/WOPTO huggingface dataset:
Patent AU-2010223115-B2 (AU)
Title: Tissue-specific aging biomarkers
Inventor: PROLLA TOMAS ALBERTO
IPC: C12Q1/68
Filed: 2010-03-10
Granted: 2016-04-21
Abstract: The invention provides methods of developing tissue-specific biomarkers of aging, sets of robust biomarkers identified by those methods, and uses of the biomarkers to identify nutrients and other functional ingredients or agents having anti-aging properties.
Patent AU-2010236022-B2 (AU)
Title: Tools for securing connectors using explosive charges and methods for using the same
Inventor: GREGORY OWEN
IPC: B25B27/00
Filed: 2010-10-26
Granted: 2013-05-16
Abstract: Abstract A tool for securing a connector on a conductor using an explosive charge includes a first tool member and a second 5 tool member movably mounted on the first tool member. A breach chamber is defined in at least one of the first and second tool members. The breech chamber is adapted to receive the explosive charge. A breech opening is defined in at least one of the first and second tool members and 10 communicates with the breech chamber. A drive member is provided. The tool is adapted to forcibly move the drive member responsive to an explosion of the explosive charge in the breech chamber. The second tool member is movable between a closed position, wherein the breech opening is is closed, and an open position, wherein the breech opening is open to allow loading and unloading of the explosive charge into and from the breech chamber, by sliding the second tool member relative to the first tool member along a slide axis and additionally pivoting the second tool 20 member relative to the first tool member about a pivot axis transverse to the slide axis. 24451171 (GHMatters) 26110/10 co coo
Patent AU-2010239084-B2 (AU)
Title: A novel formulation of meloxicam
Inventor: DODD AARON
IPC: A61K31/5415
Filed: 2010-04-23
Granted: 2014-07-24
Abstract: The present invention relates to methods for producing particles of meloxicam using dry milling processes as well as compositions comprising meloxicam, medicaments produced using meloxicam in particulate form and/or compositions, and to methods of treatment of an animal, including man, using a therapeutically effective amount of meloxicam administered by way of said medicaments.
Patent AU-2010243551-B2 (AU)
Title: Method for the production of domain antibodies
Inventor: SCHOTTE PETER
IPC: C12N15/81
Filed: 2010-04-30
Granted: 2015-03-26
Abstract: The present invention relates to a method for producing a domain antibody in a host other than E. coli, preferably yeast, comprising a) applying conditions that promote the formation of disulfide bridges in domain antibodies, or b) removing domain antibodies lacking at least one disulfide bridge, or c) a combination of (a) and (b). More specifically, the present invention relates to a method, wherein said conditions that promote the formation of disulfide brides are selected from one or more of the following: a) addition of oxidizing agents, preferably oxidizing metal ions, preferably one or more selected from Cu2+, Fe2+, Fe3+ and Zn2+; b) co-expression of the domain antibody with a thiol isomerase; c) adapting the culturing conditions by one or more selected from the following: lowering culturing temperature and/or optimizing the culturing medium, including but not limited to reduction of methanol feed for hosts requiring a methanol feed, lowering conductivity of the culture medium, addition of yeast extract and/or peptone, or any combination thereof; d) refolding the domain antibody in the presence of denaturant and redox-buffer e) treating the domain antibody by oxygenation, increasing temperature, increasing pH, high pressure or any combination thereof, and f ) combinations of any of a) through e), or wherein conditions that remove domain antibodies lacking at least one disulfide bridge are selected from a) binding domain antibodies comprising free thiol groups to suitable reactive groups, including but not limited to immobilized thiol groups, optionally under denaturing conditions; b) reverse phase high performance chromatography.
Patent AU-2010254155-B2 (AU)
Title: Method of producing naturally purified salt products
Inventor: BOLLINGER MATTHEW L
IPC: C01F5/34
Filed: 2010-05-26
Granted: 2013-10-10
Abstract: Methods for producing naturally purified salt products are disclosed. In one embodiment, a method of producing a naturally purified salt product such as magnesium sulfate heptahydrate from a salt mixture is disclosed. In another embodiment, a high purity salt product is produced. In another embodiment, other products that are produced include naturally purified sodium chloride and magnesium chloride.
Patent AU-2010258664-B2 (AU)
Title: Model systems and treatment regimes for treatment of neurological disease
Inventor: TYMIANSKI MICHAEL
IPC: A61K38/16
Filed: 2010-06-10
Granted: 2015-05-28
Abstract: The invention provides animal models and clinical trials for assessing agents for potential use in treating and effecting prophylaxis stroke and other neurological diseases, particularly those mediated at least in part by excitoxitity. The invention also provides preferred dosage and infusion regimes and pharmaceutical compositions for clinical application of such agents.
Patent AU-2010261281-B2 (AU)
Title: Transmitter apparatus, receiver apparatus, communication system and communication method
Inventor: NOGAMI TOSHIZO
IPC: H04W72/12
Filed: 2010-05-31
Granted: 2014-08-21
Abstract: A transmitter apparatus comprises a reference signal transmitting unit for transmitting both a first reference signal and a second reference signal different therefrom to each of a first receiver apparatus performing a non-cooperative communication and a second receiver apparatus performing a cooperative communication. The transmitter apparatus further comprises a notifying unit for instructing the first receiver apparatus to measure the first reference signal and for instructing the second receiver apparatus to measure the second reference signal.
Patent AU-2010273677-B2 (AU)
Title: Method and apparatus for treating a hip joint, including the provision and use of a novel suture passer
Inventor: SKINLO DAVID
IPC: A61B17/04
Filed: 2010-07-07
Granted: 2015-10-01
Abstract: A suture passer comprising: a shaft having an axis; a first jaw mounted to the shaft in alignment with the axis, the first jaw being configured to releasably support a length of suture thereon; a second jaw movably mounted to the shaft; and a needle movably mounted to the shaft, the needle having a hook and being configured to reciprocate in alignment with the axis so that the hook can selectively pass by the second jaw and engage suture releasably supported on the first jaw; wherein the first jaw comprises a spring for selectively binding the suture to the first jaw.
Patent AU-2010307347-B2 (AU)
Title: Method and system for analyzing concentrations of diverse mercury species present in a fluid medium
Inventor: ALPER HAL
IPC: B01D53/02
Filed: 2010-08-27
Granted: 2014-05-29
Abstract: A method for facilitating removal of mercury from a primary fluid stream of interest which is contaminated with organically-bound, elemental, and ionic mercury species. The stream is analyzed to establish the relative content of the organically-bound, elemental, and ionic mercury species present therein by forming a diverted side stream from the primary stream, and passing the side stream successively through three in series filter stages, the first captures organically bound mercury, the second captures elemental mercury, and the third captures ionic mercury. The side stream flow through the filter stages is continued for a predetermined period, and upon conclusion of the period the quantity of mercury collected at each of the filtration stages is determined This data is then utilized to determine the capacity of the three different filtration stages required to reduce the mercury content in the mam stream to a desired level.
Patent AU-2010334818-B2 (AU)
Title: Plants tolerant to HPPD inhibitor herbicides
Inventor: POREE FABIEN
IPC: A23L35/00
Filed: 2010-12-22
Granted: 2015-07-09
Abstract: The present invention relates to nucleic acid sequences encoding a hydroxyphenylpyruvate dioxygenase (EC 1.13.11.27, abbreviated herein as HPPD) obtained from bacteria belonging to the genus Rhodococcus as well as the proteins encoded thereby, and to a chimeric gene which comprises such nucleic acid sequence, and to the use of such nucleic acid sequences, proteins or chimeric genes for obtaining plants which are tolerant to HPPD inhibitor herbicides.
Patent AU-2010344307-B2 (AU)
Title: Energy cable
Inventor: PEREGO GABRIELE
IPC: C08K5/01
Filed: 2010-01-29
Granted: 2014-06-05
Abstract: A cable comprising at least one electrical conductor and at least one electrically insulating layer surrounding said electrical conductor, wherein the at least one electrically insulating layer comprises: (a) a thermoplastic polymer material selected from: at least one copolymer (i) of propylene with at least one olefin comonomer selected from ethylene and an α-olefin other than propylene, said copolymer having a melting point greater than or equal to 13O°C and a melting enthalpy of from 20 J/g to 90 J/g; a blend of at least one copolymer (i) with at least one copolymer (ii) of ethylene with at least one α-olefin, said copolymer (ii) having a melting enthalpy of from 0 J/g to 70 J/g; a blend of at least one propylene homopolymer with at least one copolymer (i) or copolymer (ii); a blend of at least one propylene homopolymer with at least one copolymer (i) or copolymer (ii); (b) at least one nano-sized filler; wherein at least one of copolymer (i) and copolymer (ii) is a heterophasic copolymer.
Patent AU-2010355801-B2 (AU)
Title: Store/store block instructions for communicating with adapters
Inventor: GREINER DAN
IPC: G06F9/312
Filed: 2010-11-08
Granted: 2014-04-24
Abstract: Communication with adapters of a computing environment is facilitated. Instructions are provided that explicitly target the adapters. Information provided in an instruction is used to steer the instruction to an appropriate location within the adapter.
Patent AU-2011200678-B2 (AU)
Title: Lighting fixture
Inventor: DE CARLO DOMINIC
IPC: F21V15/01
Filed: 2011-02-18
Granted: 2015-12-17
Abstract: A lighting fixture (1) for illuminating an aisle in a cinema, theatre, auditorium or the like, the lighting fixture including: a back plate (3) mountable to a seat positioned adjacent an aisle, said 5 back plate (3) having one or more mounting apertures (11) for positioning fasteners therein to fasten the back plate (3) to the seat, and a cover assembly (5) for protecting electrical components of the light fixture (1), said cover assembly being securable to the back plate (3), wherein when the cover assembly (5) is secured to the back plate (3) 10 access to the mounting apertures (11) of the back plate (3) is prevented by the cover assembly (5). Car1 Figure 3
Patent AU-2011200771-B2 (AU)
Title: Two-component mortar compound and its use
Inventor: WIELAND PHILIPP
IPC: C04B22/08
Filed: 2011-02-23
Granted: 2013-02-21
Abstract: Abstract A two-component mortar compound including a curable resin component (A) that contains 30% 5 to 45% by weight of at least one radically polymerizable resin, 30% to 45% by weight of fillers, 15% to 25% by weight of cement and 1% to 8% of a thickeners, and including a separately arranged, reaction-inhibiting curing component (B) that contains 1% to 20% by weight of a peroxide, 10% to 35% by weight of water, 40% to 80% by weight of fillers and 0.5% to 5% by weight of thickeners, with the proviso that the sum of the quantities of the constituents of the 10 resin component or of the curing component is always 100% by weight, which is characterized in that the resin component (A) contains 0.01% to 5% by weight of an organic and/or inorganic acid and/or salts and esters thereof, and the invention also describes its use to fasten anchoring means into drilled holes in mineral substrates by means of the chemical reaction of the resin component (A) with the curing component (B).
Patent AU-2011202389-B2 (AU)
Title: Sequences for the Detection and Identification of Methicillin-Resistant Staphyloccocus Aureus
Inventor: HULETSKY ANN
IPC: C12Q1/689
Filed: 2011-05-23
Granted: 2012-03-01
Abstract: The present invention describes novel SCCmec right extremity junction sequences for the detection of methicillin-resistant Staphylococcus aureus (MRSA). It relates to the use of these DNA sequences for diagnostic purposes.
Patent AU-2011205075-B2 (AU)
Title: Variable wings wind power generator having increase means of generation efficiency
Inventor: LEE IN-NAM
IPC: F03D3/02
Filed: 2011-07-29
Granted: 2013-09-19
Abstract: Abstract The present invention relates to a variable windmill wing wind power generator having a power generation efficiency increasing means. According to the present invention, the wind power generator can fold the windmill wings in the wind receiving direction and unfold the windmill wings when they are rotated by 180o from the wind receiving direction so as to minimize a resistance force exerted on a rotary force of a windmill shaft, thus increasing the power generation efficiency. The wind power generator according to the present invention can simplify the manufacturing process by the simple structure and be installed in a plural number in various places regardless of the installation location, thus maximizing the amount of power generation per unit area, achieving the industrial purpose, and generating electricity in the environment-friendly fashion without causing pollution such as greenhouse gas. [FIG. 3] 50 60a 60' -60c 30- - 112' -- 205
Patent AU-2011207602-B2 (AU)
Title: Verification mechanism
Inventor: LINDELSEE MIKE
IPC: G06Q20/00
Filed: 2011-01-19
Granted: 2015-01-22
Abstract: Systems, apparatuses, and methods for receiving a verification message with information that includes a first portion but not a second portion of an account identifier associated with an account of a consumer. Upon receiving the verification message, searching for the account using the information of the verification message.
Patent AU-2011212521-B2 (AU)
Title: sGC stimulators or sGC activators alone and in combination with PDE5 inhbitors for the treatment of Cystic Fibrosis
Inventor: SANDNER PETER
IPC: A61K31/427
Filed: 2011-02-03
Granted: 2015-11-19
Abstract: The present invention relates to soluble guanylate cyclase (sGC) and to phosphodiesterases (PDEs) and the pharmacology of sGC stimulators, sGC activators and PDE inhibitors. More particularly, the invention relates to the use of sGC stimulators and sGC activators in combination with PDE5 inhibitors for preparation of medicaments for the treatment of Cystic Fibrosis (CF).
Patent AU-2011218778-B2 (AU)
Title: Antenna System Monitor
Inventor: JONES MICHAEL WAYNE
IPC: H04W24/00
Filed: 2011-09-06
Granted: 2014-02-27
Abstract: A radio frequency (RF) monitoring apparatus (102) comprises an RF forward input port (116) and corresponding reverse input port (118) receiving, in use, forward-propagating and reflected fields respectively, of a transmitter, within a predetermined bandwidth. A tunable filter (218) of the apparatus (102) has at least one tuning signal input and is configured to provide at an RF filter output a selected frequency sub-band from within the predetermined bandwidth provided at an RF filter input which is coupled to at least one of the forward and reverse input ports (116, 118). An RF detector (220) has an RF input port coupled to the RF filter output, and is configured to generate at a detector output an electronic signal corresponding with RF power received at the RF input port. An electronic processor (202) comprises a tuning signal output coupled to the tuning signal input of the tunable filter, and a power signal input coupled to the detector output. The processor is configured to selectively generate a tuning signal at the tuning signal output corresponding with one or more specified frequency sub-bands, to record RF power signals generated by the RF detector corresponding with RF signals received at the forward and reverse input ports within the specified frequency sub-bands, and to provide monitoring signals determined from the recorded RF power signals. Embodiments are thus able to provide monitoring of individual frequency channels in an RF signal band, by configuration of the electronic processor to operate the tunable filter to select desired channel sub-bands. Measurement of forward and/or reverse-propagating fields within the selected sub-bands may be performed and corresponding power levels recorded. 4-4 x0 Am) CY) 0 t- ( x
Patent AU-2011226138-B2 (AU)
Title: Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof
Inventor: CHEVALIER YVES
IPC: C08F8/18
Filed: 2011-03-09
Granted: 2015-01-22
Abstract: The invention concerns a radiopaque, non-biodegradabie, water-insoluble iodinated benzyl ether of polyvinyl alcohol) consisting of a PVA having covalentiy grafted thereon iodinated benzyl groups comprising 1 - 4 iodine atoms per benzyl group, a process for preparing the same comprising reacting a 0 - 100 % hydrolyzed PVA with a iodinated benzyl derivative comprising 1 - 4 iodine atoms per benzyl group in a polar aprotic solvent in the presence of a base in anhydrous conditions. Said iodo-benzylether-PVA is particularly useful as embolic agent in an injectable embolizing composition. The invention also concerns an injectable embolizing composition comprising said iodo-benzylether-PVA and capable of forming a cohesive mass upon contact with a body fluid by precipitation of the iodo- benzylether-PVA. Said injectable embolizing composition is particularly useful for forming in-situ a cohesive mass in a blood vessel or into a tumor. The invention further concerns a coating composition containing said iodo-benzylether-PVA and capable of forming a radiopaque coating on a medical device. The invention further concerns particles formed of said iodo-benzylether-PVA.
Patent AU-2011232753-B2 (AU)
Title: Roller mill for comminuting brittle grinding stock
Inventor: RUTHER THOMAS
IPC: B02C4/28
Filed: 2011-10-05
Granted: 2016-02-11
Abstract: Abstract According to a first exemplary embodiment the roller mill according to the invention for comminuting brittle grinding stock essentially consists of a) at least one grinding roller rotatable about an axis of rotation, which interacts with a counter-surface in such a manner that the grinding stock 5 is comminuted between grinding roller and counter-surface, wherein at least one grinding roller is constructed as a loose roller, b) bearing blocks for bearing the grinding roller, wherein the bearing blocks are horizontally slidable and are guided in the machine frame rotatably about a vertical bearing axis intersecting the axis of rotation, 10 c) a pressing device supported on the machine frame in order to apply an adjustable grinding pressure to the grinding roller via the bearing blocks, and d) wherein at least two resilient compensation elements are associated with each bearing block in order to compensate a skewed position and/or 15 deflection of the grinding roller, wherein the compensation elements are arranged between the machine frame and the bearing blocks. The compensation elements are - in the plan view of the roll crushing mill arranged tangentially to a circle around the vertical bearing axis or constructed 20 in a circular arc around the vertical bearing axis. Lr (NN a Co ry F C' a'~CI (N(UCu(NC LfH
Patent AU-2011248407-B2 (AU)
Title: Modulators of fatty acid amide hydrolase
Inventor: KEITH JOHN M
IPC: A61P37/06
Filed: 2011-05-02
Granted: 2015-07-09
Abstract: 4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1 -carboxylic acid (4-chloro-pyridin-3-yl)-amide is described, which is useful as a FAAH modulator. 4-(2,2-Difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1 -carboxylic acid (4-chloro-pyridin-3-yl)-amide may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by fatty acid amide hydrolase (FAAH) activity, such as anxiety, pain, inflammation, sleep disorders, eating disorders, energy metabolism disorders, and movement disorders (e.g., multiple sclerosis). A method of synthesizing 4- (2,2-difluoro-benzo[1,3]dioxol-5-ylmethyl)-piperazine-1 -carboxylic acid (4- chloro-pyridin-3-yl)-amide is also disclosed.
Patent AU-2011291845-B2 (AU)
Title: Base station, relay station and method in mobile communication system
Inventor: MORIOKA YASUFUMI
IPC: H04W16/26
Filed: 2011-08-10
Granted: 2014-05-01
Abstract: A base station generates first setting information which is used both in the setting of a logical path for communication with a user device and in the setting of a logical path for communication with a relay node, and second setting information which is only used in the setting of a logical path for communication with the relay node; and transmits a first RRC message, containing the first setting information, to the relay node, and then subsequently transmits a second RRC message, containing the second setting information, to the relay node. The first setting information includes information showing the order of priority of wireless bearers according to the logical path, information showing the use method for resources in an SPS, information showing SRS resources, configuration information for an MAC sub-layer, and information relating to changes to a security encryption key due to handover; the second setting information includes at least notification information and MBSFN information.
Patent AU-2011292069-B2 (AU)
Title: Compositions comprising paulownin and/or Paulownia extracts and uses thereof
Inventor: KAUR SIMARNA
IPC: A61P17/10
Filed: 2011-08-17
Granted: 2014-09-11
Abstract: Provided are compositions comprising botanical extracts from certain species of the genus Paulownia, methods of lightening the skin therewith, and other uses thereof. Also provided are compositions comprising the compound paulownin, methods of lightening the skin therewith, and other uses thereof.
Patent AU-2011327253-B2 (AU)
Title: Method for producing pyrazolinone salt
Inventor: MIURA MASAYA
IPC: C07D231/52
Filed: 2011-11-01
Granted: 2016-03-10
Abstract: A salt represented by formula (4) is useful for the production of an active ingredient for plant disease control agents. The salt represented by formula (4) is produced through: a first step wherein a mixture, which contains a hydrocarbon solvent and an alkali metal hydroxide represented by formula A
Patent AU-2011347910-B2 (AU)
Title: Method and apparatus for treating process water
Inventor: HECKMANN HADO
IPC: C02F1/20
Filed: 2011-12-06
Granted: 2015-07-09
Abstract: The invention discloses a method and an apparatus for treating process water which is loaded with gaseous compounds and/or possibly with solids and comes from a wet-cleaning installation for cleaning process gas, e.g. from a melt-reduction subassembly or from a direct-reduction subassembly. Process water is introduced in a tank (1) in a first process stage and degassed on the basis of reduced solubility of the dissolved compounds. The tank (1) has, on its upper side, a gas-collecting chamber (1), in which the separated-off gases are collected and from which these are discharged. Likewise, the treated process water is discharged from the tank via a drainage means.